Information updates

Novalac Allergy infant formula supply update

14 June 2019

Bayer Australia Ltd (Bayer) is advising healthcare professionals and consumers that limited stock of Novalac Allergy rice protein based formula will be available and released to pharmacies in Australia during June, July and August. Intermittent supply and limited availability in pharmacies across Australia will continue until supply returns to normal levels.

Parents and carers with concerns about formula for their infant should speak to their healthcare professional about alternatives. All other Bayer Novalac products are not suitable for infants diagnosed with cow’s milk allergy. GPs, allergy specialists and paediatricians can contact the Bayer Medical Information Team on behalf of patients to discuss compassionate / critical medical cases on 1800 008 757 or email This email address is being protected from spambots. You need JavaScript enabled to view it.   

pdfNovalac Allergy Infant Formula Supply Update June 201989.46 KB

Formula options for infants diagnosed with cow’s milk allergy 

Cow’s milk based extensively hydrolysed formula (EHF)

  • EHF has been treated with enzymes to break down most of the cow’s milk proteins and it is usually the formula of first choice in cow’s milk allergic babies.
  • EHF is not suitable for babies who have had anaphylaxis to cow’s milk.
  • Some EHF brands are available without prescription.

Soy protein formula

  • Tolerated by most babies with cow's milk allergy.
  • Unsuitable for babies allergic to soy.
  • Usually only recommended in babies over six months old. 

Amino acid based formula (AAF)

AAF is usually prescribed if a baby reacts to EHF and is necessary in around one in ten babies with cow's milk allergy. It is usually prescribed when an EHF or soy protein formula is not tolerated. AAF is tolerated by most babies with cow's milk and soy allergies.

Rice protein based formula 

This formula is available without prescription. It may be used as an alternative formula to extensively hydrolysed formula (EHF) or soy protein formula and continued or changed based on specialist advice. It should not be used in babies with food protein induced enterocolitis syndrome (FPIES) to rice.

Partially hydrolysed formula (commonly labelled ‘HA’) is not a suitable formula for babies with cow’s milk allergy as enough allergenic protein is usually present to trigger an allergic reaction.

Other milk options for children over one year of age who are diagnosed with cow’s milk allergy include soy milk, calcium enriched rice, oat or nut milks
  • Soy milk, calcium enriched rice, oat or nut milks may be recommended by your doctor and/or dietitian, depending on your child’s condition.
  • It is important to check if they contain adequate levels of protein and fat for young children for growth.
  • Alternative milks enriched with calcium must contain around 120mg/100mL to be a suitable cow’s milk replacement.
  • Children with multiple food allergies may need to continue on specialised formula to meet their nutritional requirements.
  • Babies should be reviewed by a dietitian at around 12 months of age so the need for formula can be considered.

Cow’s milk derived formula/milk, lactose free formula/milk, goat’s milk formula/milk, sheep's milk formula/milk, camel’s milk, HA formula and A2 formula/milk are NOT suitable for people with cow’s milk allergy, and may cause severe allergic reactions (anaphylaxis).

For more details go to    

Mod ASCIA Member
Donate to AIFA
go to NAS website
ASCIA Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:


ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.



This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.